Zacks.com releases the latest Analyst Interview. Today’s interview is with senior analyst Chris Kallos, who discusses Humana (NYSE: HUM) and WellPoint (NYSE: WLP).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=2678.
Where do you currently stand on large-cap health benefit stocks under your coverage?
Recently, I reissued Buy recommendations on two such companies: Humana (NYSE: HUM) and WellPoint (NYSE: WLP). HUM is one of the largest publicly traded health benefit companies in the U.S. and Puerto Rico with approximately 11.5 million members in medical benefit programs and approximately 6.8 million members in specialty product programs. WellPoint is the largest publicly traded commercial health benefits company, and the largest of the Blue Cross Blue Shield (BCBS) plan providers, in terms of membership in the U.S.
What is your current outlook for managed care overall?
Our outlook for the managed care industry is neutral, albeit with a positive bias. This industry has benefited in the last few years from favorable demographic trends and expanded Medicare reimbursements. We believe managed care organizations will continue to benefit from current developments in consumer directed health, growth of self-insurance/individual and small group plans, and more recent introductions of Medicare part D.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks Profit from the Pros e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2679.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4581.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contacts:
Mark Vickery
Zacks Web Content Editor
312-265-9380
Visit:
www.zacks.com
